MSB 7.69% $1.19 mesoblast limited

MSB Trading 2021 - paradigm shift, page-1790

  1. 15,106 Posts.
    lightbulb Created with Sketch. 820
    Not only are Novartis not pulling out, but they are going to get Ards treatment approved by the FDA into a commercialised treatment, Novartis have huge weight and are experienced in getting drugs/treatments commercialised.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.